Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews From: Health Canada News release Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews April 9, 2019 -…
Optimizing the Use of Real World Evidence to Inform Regulatory Decision-Making Health Products and Food Branch Notice April 16, 2019 Health Canada’s Evolving Approach to Leveraging Real World Evidence (RWE) for Drug Regulatory Decisions Health Canada is delighted to announce that…
Consultation on Draft Guidance: Accelerated Review of Human Drug Submissions Current status: Closed The consultation ran from May 7, 2019 to July 21, 2019. Health Canada is announcing a 75 day consultation on the draft Guidance: Accelerated Review of Human Drug Submissions. The…
Consultation on the Draft Guidance: Public or Canadian Armed Forces Health Emergencies - Drugs for Immediate Use or Stockpiling From Health Canada Current status: Closed This consultation ran from May 10, 2019 to July 19, 2019. This draft guidance provides information on the…
Consultation - Draft Guidance Document for Industry and Practitioners on the Special Access Program (SAP) for Drugs From Health Canada Current status: Closed This consultation ran from May 10, 2019 to July 19, 2019. This draft guidance provides information on the interpretation…
Foreign Risk Notification, Annual Summary Reports, and Issue-related Analysis of Safety and Effectiveness for Medical Devices - Draft Guidance Document June 2019 PDF Version (465 K) Table of Contents Introduction Definitions Foreign Risk Notification (Sections 61.2 and 61.3)…
Public release of clinical information We are updating how we disclose the clinical information used to assess the safety and effectiveness of drugs and medical devices. This information can have widespread benefits for: patients the health care system For example, giving more…
Health products cost recovery initiatives On this page Our approach to fees History of fees for health products Consultation and engagement Contact us Our approach to fees Health Canada's approach to cost recovery regimes for health products is guided by the principles of:…
Strengthening the use of real world evidence and regulations for medical devices This project aims to improve our ability to monitor medical device safety and effectiveness across the product life cycle. It will also help us to develop new regulatory options to prevent and…
Strengthening the use of real world evidence for drugs From Health Canada This project aims to improve our ability to assess and monitor the safety, efficacy and effectiveness of drugs across the drug life cycle. It will do this by optimizing the use of real world evidence (RWE)…
Page 2331 sur 3977Affichage de 23301 à 23310 sur 39762
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
